Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Quince Therapeutics (QNCX)
NASDAQ:QNCX
Quince Therapeutics (QNCX) Stock Price & Analysis
501 Followers
QNCX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.63 - $1.70
Previous Close$0.73
Volume53.16K
Average Volume (3M)109.36K
Market Cap
$31.33M
Enterprise Value-$680.96K
Total Cash (Recent Filing)$46.01M
Total Debt (Recent Filing)$14.00M
Price to Earnings (P/E)―
Beta1.15
Next Earnings
Aug 06, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.76
Shares Outstanding43,215,233
10 Day Avg. Volume157,016
30 Day Avg. Volume109,356
Standard Deviation0.32
R-Squared0.04
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-5.69
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.02
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Quince Therapeutics News
PremiumCompany Announcements
Quince Therapeutics Appoints Rajiv Patni to Board of Directors
PremiumCompany Announcements
Quince Therapeutics Executive Compensation and Stock Option Update
Ownership Overview
52.87% Insiders
3.93% Mutual Funds
12.97% Other Institutional Investors
30.23% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
QNCX FAQ
What was Quince Therapeutics’s price range in the past 12 months?
Quince Therapeutics lowest stock price was $0.63 and its highest was $1.70 in the past 12 months.
What is Quince Therapeutics’s market cap?
Currently, no data Available
When is Quince Therapeutics’s upcoming earnings report date?
Quince Therapeutics’s upcoming earnings report date is Aug 06, 2024 which is in 34 days.
How were Quince Therapeutics’s earnings last quarter?
Currently, no data Available
Is Quince Therapeutics overvalued?
According to Wall Street analysts Quince Therapeutics’s price is currently Overvalued.
Does Quince Therapeutics pay dividends?
Quince Therapeutics does not currently pay dividends.
What is Quince Therapeutics’s EPS estimate?
Quince Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Quince Therapeutics have?
Quince Therapeutics has 43,215,233 shares outstanding.
What happened to Quince Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Quince Therapeutics?
Among the largest hedge funds holding Quince Therapeutics’s share is Gotham Asset Management LLC. It holds Quince Therapeutics’s shares valued at N/A.
---
Quince Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
QNCX Sentiment 100%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 0.5%
Last 30 Days ▲ 0.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-51.82%
12-Months-Change
Fundamentals
Return on Equity
-36.84%
Trailing 12-Months
Asset Growth
70.70%
Trailing 12-Months
Company Description
Quince Therapeutics
Cortexyme, Inc. is a biopharmaceutical company, which develops therapeutics based on data supporting a new theory of the cause of Alzheimer's and other neurodegenerative disorders. Its product, COR388, is in clinical trial. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.
---
QNCX Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---